Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%

NCT03519386 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

590

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

COMBINATION_PRODUCT: G2-TR intraocular implant containing travoprost
DRUG: Sham surgery + active-comparator eye drops

Sponsor

Glaukos Corporation